NaviCam for Barrett's Esophagus
(DS-MCE-BE Trial)

Recruiting in Palo Alto (17 mi)

Overseen bySwathi Eluri

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Mayo Clinic

No Placebo Group

Trial Summary

What is the purpose of this trial?Using a non-invasive capsule system to achieve optimal viewing angles of the esophagus for detection of Barrett's esophagus

Eligibility Criteria

This trial is for individuals who may have Barrett's Esophagus, a condition where the esophageal lining changes. Specific eligibility criteria are not provided, but typically participants should be adults with suspected or known Barrett's Esophagus and in stable health.

Inclusion Criteria

I have Barrett's Esophagus or severe acid reflux with additional risk factors.

I am 22 or older and had an endoscopy within the last year.

Exclusion Criteria

I have had surgery or a blockage in my small intestine.

Presence of pacemaker or implanted cardiac defibrillator

Inability to comprehend or read the consent form

+7 more

Participant Groups

The trial is testing the NaviCam Detachable String Capsule, a non-invasive device designed to provide detailed views of the esophagus to detect Barrett's Esophagus without requiring traditional endoscopy.

3Treatment groups

Experimental Treatment

Group I: Short Segment Barrett's Esophagus (SSBE)Experimental Treatment1 Intervention

Subjects diagnosed with Short Segment Barrett's Esophagus (SSBE)

Group II: Long Segment Barrett's Esophagus (LSBE)Experimental Treatment1 Intervention

Subjects diagnosed with Long Segment Barrett's Esophagus (LSBE)

Group III: Gastro Esophageal Reflux DiseaseExperimental Treatment1 Intervention

Subjects with Gastro Esophageal Reflux Disease (GERD) who are eligible for Barrett's Esophagus screening